Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

NCT02659930 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

NIH

Sponsor class

Conditions

Kaposi Sarcoma

Interventions

DRUG: liposomal doxorubicin
DRUG: pomalidomide

Sponsor

National Cancer Institute (NCI)